NeuroOne Medical Technologies Corporation (NMTC)

NMTC Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	29	31	21	27	47	29
Market Cap Growth	-15.68%	43.23%	-22.25%	-42.21%	66.31%	12.96%
Enterprise Value	28	29	18	17	39	32
Last Close Price	0.58	0.99	0.89	1.69	3.95	3.85
PS Ratio	3.01	8.83	6.25	12.92	195.11	14.79
PB Ratio	16.22	37.11	3.41	2.85	7.23	13.80
P/TBV Ratio	27.09	40.42	3.46	2.89	7.38	14.93
EV/Sales Ratio	4.86	8.45	5.41	8.23	159.21	16.47
Debt / Equity Ratio	0.28	0.32	0.03	0.02	0.05	0.68
Asset Turnover	1.17	0.51	0.33	0.20	0.04	0.73
Inventory Turnover	4.89	3.41	6.94	12.88	-	-
Quick Ratio	0.93	0.74	2.97	3.61	5.88	1.71
Current Ratio	2.13	2.09	4.08	3.93	6.17	1.76
Return on Equity (ROE)	-265.18%	-348.39%	-149.61%	-123.77%	-230.81%	-3292.36%
Return on Assets (ROA)	-83.48%	-110.33%	-71.43%	-60.39%	-100.59%	-115.79%
Return on Capital (ROIC)	-151.92%	-197.70%	-92.01%	-75.19%	-123.55%	-274.63%
Earnings Yield	-22.79%	-40.38%	-55.68%	-36.50%	-20.99%	-47.86%
FCF Yield	-17.10%	-36.49%	-62.31%	-28.46%	-18.29%	-12.45%
Buyback Yield / Dilution	-32.72%	-47.69%	-13.27%	-49.56%	-97.52%	-37.01%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q